Upon completion of his Doctorate in pathology at the Hiroshima University School of Medicine in Japan in 1985, Kiyomi Taniyama commenced work in the field of clinical pathology at Shizuoka Prefectural General Hospital, Japan, in 1987. He moved to Kure Kyosai Hospital in the Hiroshima Prefecture in 1992, and then joined NHO KMC CCC in 2002. His major research field was originally GI cancer, with a special interest in cancer metastasis (Taniyama et al. 1997). In the rapidly changing world of cancer research, he expanded his horizons by learning molecular techniques and laser capture microdissection at the University of California, San Diego Cancer Center, and the Department of Pathology at UCSD in 1998-1999. He reported on PTEN expression in sporadic colorectal tumors in 2001, and an intraoperative detection of micrometastasis in lymph nodes by one-step nucleic acid amplification in 2006. Recently, his research interests have extended to breast and uterine cervical cancers due to the rapid increase of patients affected with these cancers in Japan. Between 2008 and 2010, he organized a study group for multihospital analysis of uterine cervical lesions with reference to HPV infection and liquid-base cytology in Japan. Abnormal methylation of some genes was found to be predictive indicators of disease progression from CIN 1 lesions of uterine cervix in this analysis. On the other hand, he won the 10th Breast Cancer Award from the Breast Cancer Society of Japan in 2009. Currently, he has developed a novel system of autoanalysis for assessment of immunohistochemistry of breast cancer with a virtual microscopy and specified software. With this system, a new protocol for breast cancer adjuvant chemotherapy is proposed by his research group.
Biography Updated on 31 March 2013